Latest Breaking News On - While zevra - Page 1 : comparemela.com

Zevra Therapeutics to Participate at Upcoming Investor Conferences

Zevra Therapeutics to Participate at Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNeilf mcfarlaneIgnacio guerrero rosDavid schullNichol ochsnerZevra therapeutics incExchange commissionCompany expanded access programHealth care conferenceChief executive officerDana pointZevra therapeuticsExpanded access programNote concerning forward looking statementsPrivate securities litigation reform actAnnual report

Zevra Therapeutics To Participate At Upcoming Investor Conferences

Zevra Therapeutics To Participate At Upcoming Investor Conferences
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesIgnacio guerrero rosDavid schullNichol ochsnerNeilf mcfarlaneCompany expanded access programZevra therapeutics incHealth care conferenceExchange commissionChief executive officerAnnual health care conferenceDana pointZevra therapeuticsExpanded access programNote concerning forward looking statementsPrivate securities litigation reform act

Zevra Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - Zevra Therapeutics (NASDAQ:ZVRA)

CELEBRATION, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will present at the upcoming Oppenheimer

David schullNichol ochsnerIgnacio guerrero rosHealthcare life sciences conferenceZevra therapeutics incCompany expanded access programExchange commissionAnnual healthcare life sciences conferenceInvestor relationsZevra therapeuticsExpanded access programNote concerning forward looking statementsPrivate securities litigation reform actAnnual reportQuarterly reportWhile zevra

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David schullNichol ochsnerNeilf mcfarlaneIgnacio guerrero rosZevra therapeutics incEuropean medicines agencyCompany expanded access programExchange commissionDrug administrationNew drug applicationPrescription drug user fee actChief executive officerOrphan drugFast trackBreakthrough therapyRare pediatric disease

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Nichol ochsnerDavid schullNeilf mcfarlaneIgnacio guerrero rosCompany expanded access programEuropean medicines agencyExchange commissionZevra therapeutics incGlobenewswire incDrug administrationNew drug applicationPrescription drug user fee actChief executive officerOrphan drugFast trackBreakthrough therapy